Congress trades in Takeda Pharmaceutical Company Limited (TAK)
Healthcare · Drug Manufacturers - Specialty & Generic
2 members of Congress have disclosed 2 trades in Takeda Pharmaceutical Company Limited (TAK) since 2023: 0 buys and 2 sales. The most recent was disclosed on Sep 5, 2023.
- Trades disclosed
- 2
- Members trading
- 2
- Buys / sells
- 0 / 2
- Reported value
- $30K–$100K
Who traded TAK
MemberBuysSalesLast disclosed
- Rep. Virginia Foxx (R-NC-5)0 buys · 1 sale01Sep 5, 2023
- Rep. Daniel S. Goldman (D-NY-10)0 buys · 1 sale01Aug 13, 2023
All trades
DisclosedTradeAmount
- Sep 5, 2023$15K–$50K
Rep. Virginia Foxx (R-NC-5)
Sold (full) Takeda Pharmaceutical Company Limited TAK
$15K–$50K · Traded Aug 29, 2023 · disclosed Sep 5, 2023 · Joint
- Aug 13, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
Sold (full) Takeda Pharmaceutical Company Limited TAK
$15K–$50K · Traded Jul 10, 2023 · disclosed Aug 13, 2023
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.